Vandortuzumab
Vandortuzumab is a CHO-expressed humanized antibody targeting STEAP1. Vandortuzumab has a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.5 kDa. The isotype control for Vandortuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001) .
Product Specifications
Product Name Alternative
DSTP-3086S Antibody; RG-7450 Antibody
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vandortuzumab.html
Purity
99.00
Molecular Weight
(145.5 kDa)
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-60629R-PerCP-Cy5.5 100 µL
RPA2 Recombinant Antibody, PerCP-Cy5.5 Conjugated
Sign In for Pricing
View Details 
034583-HRP 200 µL
DENND1B, NT (DENND1B, C1orf218, FAM31B, DENN domain-containing protein 1B, Connecdenn 2, Protein FAM31B) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details 
MBS7055373 Inquire
Recombinant Human Membrane metallo-endopeptidase-like 1 (MMEL1), partial
Sign In for Pricing
View Details